Point of Care Diagnostics companies

Report ID: 95
Published Date: May 23, 2025
Report Format: PDF, PPT

Buy Now

Companies Dominating the Point of Care Diagnostics Landscape

The progress in globalization of the point of care diagnostics market is highly influenced by cutting-edge innovations and commercial initiatives from key players. Following the same pathway, Roche, Abbott, and Siemens collectively attained control over 45.2% of revenue share in this sector. Testifying to this accomplishment, Siemens acquired the ability to reduce diagnostic delays in hospitals across Europe by amalgamating POC tools with electronic health records (EHRs). On the other hand, leaders in the emerging landscapes in the point of care diagnostics market are collaborating with dedicated government entities to captivate new business opportunities produced by new initiatives.

Top 20 of such key players are mentioned below:

Company	Country	Market Share	Industry Focus
Roche Diagnostics	Switzerland	18.5%	Molecular POC (Cobas Liat), infectious disease tests
Abbott Laboratories	U.S.	15.3%	Rapid diagnostics (BinaxNOW, i-STAT), cardiometabolic tests
Siemens Healthineers	Germany	12.1%	Immunoassays, AI-integrated POC devices
Danaher (Beckman Coulter, Cepheid)	U.S.	10.3%	Molecular POC (Xpert tests), microfluidics
BD (Becton Dickinson)	U.S.	8.2%	Infectious disease tests (Veritor), biosensors
QuidelOrtho	U.S.	xx%	Lateral flow assays (Sofia), respiratory tests
bioMérieux	France	xx%	Sepsis POC tests, antimicrobial resistance detection
Sysmex Corporation	Japan	xx%	Hematology POC analyzers, AI-driven diagnostics
ARKRAY	Japan	xx%	Glucose monitoring, HbA1c POC devices
Trinity Biotech	Ireland	xx%	HIV/HBV rapid tests, tropical disease diagnostics
SD Biosensor	South Korea	xx%	Low-cost LFAs, COVID-19 antigen tests
Thermo Fisher Scientific	U.S.	xx%	PCR-based POC, portable analyzers
Chembio Diagnostics	U.S.	xx%	Tropical disease tests (DPP HIV-Syphilis assay)
Eiken Chemical	Japan	xx%	TB/HPV molecular POC tests
PTS Diagnostics	U.S.	xx%	CardioChek lipid analyzers
Trividia Health	U.S.	xx%	Diabetes care (TRUEmetrix glucose meters)
J. Mitra & Co.	India	xx%	Affordable rapid tests for HIV/malaria
Boditech Med	South Korea	xx%	iChroma immunoassay systems
Tulip Diagnostics	India	xx%	Rapid diagnostic kits for infectious diseases
ACON Laboratories	U.S.	xx%	At-home pregnancy/glucose tests

Browse key industry insights with market data tables & charts from the report:

Point of Care Diagnostics Market Size | Growth Report 2037

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of point of care diagnostics is assessed at USD 46.7 billion.

Point of Care Diagnostics Market size was valued at USD 42.7 billion in 2024 and is likely to cross USD 98.6 billion by 2037, expanding at more than 9.5% CAGR during the forecast period i.e., between 2025-2037.

North America industry is likely to account for largest revenue share of 38.3% by 2037, attributed to increasing awareness amongst individuals for the availability of such testing kits, along with presence of the key companies operating in the market

The major players in the market are Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Danaher (Beckman Coulter, Cepheid), BD (Becton Dickinson), QuidelOrtho, bioMérieux, Sysmex Corporation, ARKRAY, Trinity Biotech, SD Biosensor, Thermo Fisher Scientific, Chembio Diagnostics, Eiken Chemical, PTS Diagnostics, Trividia Health, J. Mitra & Co., Boditech Med, Tulip Diagnostics, ACON Laboratories.